Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inotiv Inc (NOTV)

Inotiv Inc (NOTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,555
  • Shares Outstanding, K 34,367
  • Annual Sales, $ 513,020 K
  • Annual Income, $ -68,630 K
  • EBIT $ 25 M
  • EBITDA $ 86 M
  • 60-Month Beta 4.21
  • Price/Sales 0.04
  • Price/Cash Flow 6.38
  • Price/Book 0.16
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.86
  • Most Recent Earnings $-0.14 on 12/03/25
  • Next Earnings Date 02/04/26 [--]
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 295.72% (-134.78%)
  • Historical Volatility 87.75%
  • IV Percentile 82%
  • IV Rank 28.36%
  • IV High 814.43% on 11/13/25
  • IV Low 90.38% on 11/17/25
  • Expected Move (DTE 2) 1.7340 (293.95%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 77
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 4,235
  • Open Int (30-Day) 3,923
  • Expected Range 0.0000 to 2.3239

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +237,957.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4700 +27.66%
on 12/29/25
0.7572 -20.76%
on 12/15/25
-0.1642 (-21.49%)
since 12/12/25
3-Month
0.4700 +27.66%
on 12/29/25
1.4850 -59.60%
on 10/15/25
-0.8100 (-57.45%)
since 10/14/25
52-Week
0.4700 +27.66%
on 12/29/25
4.8000 -87.50%
on 02/04/25
-3.6200 (-85.78%)
since 01/14/25

Most Recent Stories

More News
Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

WEST LAFAYETTE, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical...

NOTV : 0.6058 (+1.29%)
Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

WEST LAFAYETTE, Ind., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization (CRO) specializing in nonclinical...

NOTV : 0.6058 (+1.29%)
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update

–  Fourth quarter fiscal 2025 revenue up 5.9% to $138.1 million –  Fiscal 2025 revenue increased 4.5% to $513.0 million –  Fourth quarter fiscal 2025 operating loss decreased 48.5% to $6.8 million...

NOTV : 0.6058 (+1.29%)
Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™

WEST LAFAYETTE, Ind., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Inotiv today announced it ranked 182 nd on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media,...

NOTV : 0.6058 (+1.29%)
Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025

WEST LAFAYETTE, Ind., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”) , a leading contract research organization specializing in nonclinical and analytical...

NOTV : 0.6058 (+1.29%)
Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results

Preliminary Expected Fourth Quarter 2025 Revenue of $137.5 to $138.5 Million Preliminary Expected Full Year 2025 Revenue of $512.5 to $513.5 Million Updated Time of Company Presentation at Jefferies...

NOTV : 0.6058 (+1.29%)
Halper Sadeh LLC Encourages Inotiv, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

NOTV : 0.6058 (+1.29%)
Inotiv, Inc. to Participate in Three Investor Conferences in November 2025

WEST LAFAYETTE, Ind., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...

NOTV : 0.6058 (+1.29%)
Inotiv, Inc. to Participate in Three Investor Conferences in September 2025

WEST LAFAYETTE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...

NOTV : 0.6058 (+1.29%)
CORRECTING and REPLACING - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update

In a release issued under the same headline on August 6, 2025 by Inotiv, Inc. (NASDAQ: NOTV), please note that the amount of the recent draw request on the revolving credit facility has been corrected. The...

NOTV : 0.6058 (+1.29%)

Business Summary

Inotiv Inc. is a pharmaceutical development company. It involved in providing contract research services and monitoring instruments to emerging pharmaceutical companies. Inotiv Inc., formerly known as Bioanalytical Systems Inc., is based in WEST LAFAYETTE, Ind.

See More

Key Turning Points

3rd Resistance Point 0.6647
2nd Resistance Point 0.6374
1st Resistance Point 0.6177
Last Price 0.6058
1st Support Level 0.5707
2nd Support Level 0.5434
3rd Support Level 0.5237

See More

52-Week High 4.8000
Fibonacci 61.8% 3.1459
Fibonacci 50% 2.6350
Fibonacci 38.2% 2.1241
Last Price 0.6058
52-Week Low 0.4700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar